Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Effect of direct renin inhibitor on left ventricular remodeling in patients with primary acute myocardial infarction.

Ozaki Y, Imanishi T, Tanimoto T, Teraguchi I, Nishiguchi T, Orii M, Shiono Y, Shimamura K, Yamano T, Ino Y, Yamaguchi T, Kubo T, Akasaka T.

Int Heart J. 2014;55(1):17-21. Epub 2014 Jan 27.

PMID:
24463924
[PubMed - indexed for MEDLINE]
Free Article
2.

Effect of direct renin inhibitor, aliskiren, on peripheral blood monocyte subsets and myocardial salvage in patients with primary acute myocardial infarction.

Ozaki Y, Imanishi T, Tanimoto T, Kashiwagi M, Tsujioka H, Sougawa H, Orii M, Shiono Y, Shimamura K, Ishibashi K, Komukai K, Ino Y, Kitabata H, Akasaka T.

Circ J. 2012;76(6):1461-8. Epub 2012 Mar 28.

PMID:
22453004
[PubMed - indexed for MEDLINE]
Free Article
3.

Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction.

Solomon SD, Shin SH, Shah A, Skali H, Desai A, Kober L, Maggioni AP, Rouleau JL, Kelly RY, Hester A, McMurray JJ, Pfeffer MA; Aliskiren Study in Post-MI Patients to Reduce Remodeling (ASPIRE) Investigators.

Eur Heart J. 2011 May;32(10):1227-34. doi: 10.1093/eurheartj/ehq522. Epub 2011 Feb 10.

PMID:
21317148
[PubMed - indexed for MEDLINE]
Free Article
4.

Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy.

Solomon SD, Appelbaum E, Manning WJ, Verma A, Berglund T, Lukashevich V, Cherif Papst C, Smith BA, Dahlöf B; Aliskiren in Left Ventricular Hypertrophy (ALLAY) Trial Investigators.

Circulation. 2009 Feb 3;119(4):530-7. doi: 10.1161/CIRCULATIONAHA.108.826214. Epub 2009 Jan 19.

PMID:
19153265
[PubMed - indexed for MEDLINE]
Free Article
5.

High-sensitivity C-reactive protein and left ventricular remodeling in patients with acute myocardial infarction.

Uehara K, Nomura M, Ozaki Y, Fujinaga H, Ikefuji H, Kimura M, Chikamori K, Nakaya Y, Ito S.

Heart Vessels. 2003 May;18(2):67-74.

PMID:
12756602
[PubMed - indexed for MEDLINE]
6.

Effects of angiotensin converting enzyme inhibitor, angiotensin II type I receptor blocker and their combination on postinfarcted ventricular remodeling in rats.

Zhang RY, Wang LF, Zhang L, Meng XN, Li SJ, Wang WR.

Chin Med J (Engl). 2006 Apr 20;119(8):649-55.

PMID:
16635409
[PubMed - indexed for MEDLINE]
Free Article
7.

Aliskiren and valsartan combination therapy for the management of hypertension.

Epstein BJ.

Vasc Health Risk Manag. 2010 Sep 7;6:711-22. Review.

PMID:
20859542
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?

Athyros VG, Mikhailidis DP, Kakafika AI, Tziomalos K, Karagiannis A.

Expert Opin Pharmacother. 2007 Apr;8(5):529-35. Review.

PMID:
17376010
[PubMed - indexed for MEDLINE]
9.

Dual renin angiotensin system blockade in patients with acute myocardial infarction and preserved left ventricular systolic function.

Suşan M, Petrescu L, Riviş AI, Suşan RM, Burghină D, Dan R, Cozma D, Drăgulescu SI.

Rom J Intern Med. 2005;43(3-4):187-98.

PMID:
16812979
[PubMed - indexed for MEDLINE]
10.

Combination angiotensin converting enzyme and direct renin inhibition in heart failure following experimental myocardial infarction.

Connelly KA, Advani A, Advani S, Zhang Y, Thai K, Thomas S, Krum H, Kelly DJ, Gilbert RE.

Cardiovasc Ther. 2013 Apr;31(2):84-91. doi: 10.1111/j.1755-5922.2011.00292.x. Epub 2011 Jul 4.

PMID:
21884026
[PubMed - indexed for MEDLINE]
11.

Effects of two inhibitors of renin-angiotensin system on attenuation of postoperative remodeling after left ventricular aneurysm repair in rats.

Nomoto T, Nishina T, Tsuneyoshi H, Miwa S, Nishimura K, Komeda M.

J Card Surg. 2003 Jul-Aug;18 Suppl 2:S61-8.

PMID:
12930272
[PubMed - indexed for MEDLINE]
12.

Effects of valsartan, an angiotensin II receptor blocker, on coronary atherosclerosis in patients with acute myocardial infarction who receive an angiotensin-converting enzyme inhibitor.

Yano H, Hibi K, Nozawa N, Ozaki H, Kusama I, Ebina T, Kosuge M, Tsukahara K, Okuda J, Morita S, Umemura S, Kimura K.

Circ J. 2012;76(6):1442-51. Epub 2012 Apr 4.

PMID:
22473458
[PubMed - indexed for MEDLINE]
Free Article
13.

[Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases].

Horký K.

Vnitr Lek. 2010 Feb;56(2):120-6. Review. Czech.

PMID:
20329582
[PubMed - indexed for MEDLINE]
14.

Changes of matrix metalloproteinase-9 level is associated with left ventricular remodeling following acute myocardial infarction among patients treated with trandolapril, valsartan or both.

Miyazaki S, Kasai T, Miyauchi K, Miyazaki T, Akimoto Y, Takagi A, Aihara K, Kawamura M, Suwa S, Kojima S, Sumiyoshi M, Daida H.

Circ J. 2010 Jun;74(6):1158-64. Epub 2010 Apr 6.

PMID:
20378999
[PubMed - indexed for MEDLINE]
Free Article
15.

Inhibitory effect of candesartan cilexetil on left ventricular remodeling after myocardial infarction.

Suzuki H, Kusuyama T, Omori Y, Soda T, Tsunoda F, Sato T, Shoji M, Iso Y, Kondo T, Koba S, Geshi E, Katagiri T.

Int Heart J. 2006 Sep;47(5):715-25.

PMID:
17106142
[PubMed - indexed for MEDLINE]
Free Article
16.

Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure.

McMurray JJ, Pitt B, Latini R, Maggioni AP, Solomon SD, Keefe DL, Ford J, Verma A, Lewsey J; Aliskiren Observation of Heart Failure Treatment (ALOFT) Investigators.

Circ Heart Fail. 2008 May;1(1):17-24. doi: 10.1161/CIRCHEARTFAILURE.107.740704.

PMID:
19808266
[PubMed - indexed for MEDLINE]
Free Article
17.

Additive renoprotective effects of aliskiren on angiotensin receptor blocker and calcium channel blocker treatments for type 2 diabetic patients with albuminuria.

Abe M, Maruyama N, Suzuki H, Fujii Y, Ito M, Yoshida Y, Okada K, Soma M.

Hypertens Res. 2012 Aug;35(8):874-81. doi: 10.1038/hr.2012.45. Epub 2012 May 17.

PMID:
22592665
[PubMed - indexed for MEDLINE]
18.
19.

Aliskiren improves left ventricular dysfunction and reduces cardiac dilation in Syrian cardiomyopathic hamsters.

Crespo MJ, Cangiano JL, Altieri PI, Escobales N.

J Cardiovasc Pharmacol. 2012 Jun;59(6):547-52. doi: 10.1097/FJC.0b013e31824e5273.

PMID:
22370958
[PubMed - indexed for MEDLINE]
20.

Effects of aliskiren on the fibrinolytic system in patients with coronary artery disease receiving angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor blocker.

Ishibashi K, Kurisu S, Kato Y, Mitsuba N, Dohi Y, Nishioka K, Kihara Y.

Heart Vessels. 2013 Jan;28(1):7-11. doi: 10.1007/s00380-011-0204-7. Epub 2011 Nov 2.

PMID:
22045153
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk